Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Given Consensus Rating of "Hold" by Brokerages

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) has been given an average rating of "Hold" by the five analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $21.60.

A number of analysts recently weighed in on the stock. StockNews.com upgraded shares of Calumet Specialty Products Partners to a "sell" rating in a research report on Monday, November 18th. HC Wainwright reiterated a "buy" rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a report on Monday. UBS Group lowered shares of Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and decreased their price target for the company from $20.50 to $15.00 in a report on Tuesday, February 4th. Finally, TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their price objective for the company from $26.00 to $16.00 in a research report on Tuesday.

Get Our Latest Stock Report on Calumet Specialty Products Partners

CLMT traded down $0.48 during trading on Friday, reaching $12.98. 2,104,597 shares of the company's stock were exchanged, compared to its average volume of 1,453,818. The company's fifty day moving average price is $17.98 and its 200-day moving average price is $19.22. The firm has a market capitalization of $1.11 billion, a PE ratio of -4.68 and a beta of 1.88. Calumet Specialty Products Partners has a fifty-two week low of $9.97 and a fifty-two week high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to analyst estimates of $921.76 million. During the same period last year, the firm earned ($0.59) earnings per share. The firm's revenue for the quarter was down 2.8% on a year-over-year basis. Research analysts forecast that Calumet Specialty Products Partners will post -3.02 earnings per share for the current fiscal year.

In other news, Director Jennifer Straumins sold 37,861 shares of the business's stock in a transaction dated Wednesday, December 18th. The stock was sold at an average price of $21.42, for a total value of $810,982.62. Following the sale, the director now directly owns 1,184,589 shares in the company, valued at $25,373,896.38. The trade was a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 2.91% of the stock is owned by insiders.

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

CLMT(Ad)(Ad)